Immunomic Therapeutics

About:

Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.

Website: http://www.immunomix.com

Twitter/X: immunomix

Top Investors: Life Sciences Greenhouse of Pennsylvania, Brainchild Holdings, Keiretsu Forum Northwest, Mid Atlantic Bio Angels, Minority Angel Investor Network

Description:

Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines for the treatment of allergy and other human health targets. The company was founded in 2005 and is based in Lancaster, Pennsylvania.